TMEM are responsible for vascular endothelial growth factor A (VEGFA)-driven transient vascular leakiness and tumor cell intravasation and predict distant metastatic disease in breast cancer patients (Harney et al., 2015, Rohan et al., 2014, Sparano et al., 2017). The gene discussed is VEGFA; the disease is breast cancer.